SCHEMBL3666192

SCHEMBL3666192

O=C(OCl)c1cccc([N+](=O)[O-])c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.67
ALDH1A1 P00352 3/20 0.67
CES2 O00748 1/20 0.66
CES1 P23141 1/20 0.66
TP53 P04637 1/20 0.64
MAPT P10636 5/20 0.61
KMT2A Q03164 4/20 0.61
MEN1 O00255 3/20 0.61
POLB P06746 2/20 0.61
CTDSP1 Q9GZU7 1/20 0.61
ALOX5 P09917 1/20 0.57
KDM4E B2RXH2 3/20 0.56
L3MBTL1 Q9Y468 3/20 0.56
NPSR1 Q6W5P4 1/20 0.56
PRSS1 P07477 1/20 0.54
PRSS2 P07478 1/20 0.54
PRSS3 P35030 1/20 0.54
LMNA P02545 3/20 0.53
NPC1 O15118 1/20 0.53
CYP1A2 P05177 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4721013 0.86 CES2 (0.70) TSHRALDH1A1CES2CES1TP53
SCHEMBL7656493 0.86 CES2 (0.70) TSHRALDH1A1CES2CES1TP53
SCHEMBL828959 0.84 TSHR (0.69) TSHRALDH1A1CES2CES1TP53
SCHEMBL17297123 0.83 TSHR (0.67) TSHRALDH1A1CES2CES1TP53
SCHEMBL31103641 0.83 MEN1 (0.76) TSHRALDH1A1CES2CES1TP53
SCHEMBL7013007 0.83 CES2 (0.66) TSHRALDH1A1CES2CES1TP53
SCHEMBL19285363 0.83 CES2 (0.66) TSHRALDH1A1CES2CES1TP53
SCHEMBL27903047 0.83 CES2 (0.66) TSHRALDH1A1CES2CES1TP53
SCHEMBL1572442 0.83 MEN1 (0.76) TSHRALDH1A1CES2CES1TP53
SCHEMBL6965282 0.83 CES2 (0.66) TSHRALDH1A1CES2CES1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1199396-A Novel azepanes and their ring homologues for therapy and prophylaxis of protein kinase mediated diseases HOFFMANN LA ROCHE (CH) 1998-11-18 CN claimed
WO-2020132582-A1 STING AGONISTS AND USES THEREOF NIMBUS TITAN, INC. (US) 2020-06-25 WO disclosed
CN-104030987-A DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO SA 2014-09-10 CN disclosed
EP-2240485-A1 TRICYCLIC COMPOUNDS HAVING CORTICOTROPIN-RELEASING FACTOR ANTAGONISTIC ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Takeda Pharmaceutical Company Limited (JP) 2010-10-20 EP disclosed
WO-2009093747-A1 TRICYCLIC COMPOUNDS HAVING CORTICOTROPIN-RELEASING FACTOR ANTAGONISTIC ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-07-30 WO disclosed
EP-0517871-A1 NOVEL NITROANILIDES AND THEIR PREPARATION. KODAK LTD (GB) 1992-12-16 EP disclosed
WO-1992011230-A1 NOVEL NITROANILIDES AND THEIR PREPARATION KODAK LIMITED (GB) 1992-07-09 WO disclosed